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ABSTRACT We have purified a protein from Necturus
maculosus gallbladder cells that forms chloride channels in an
artificial membrane. The same protein apparently can form
channels that are highly selective for chloride but can have
conductances varying from 9 to about 150 pS. The high-
conductance channels are blocked by the monoclonal antibody
used to purify the protein, but this antibody has no effect on the
9-pS channels. The observation that gating of the low- and
high-conductance states is independent and that the antibody
affects only the latter has implications regarding the control of
chloride conductance in cell membranes and the different types
of channels described in those cells.
Chloride channels have been studied in a wide variety of cells
(1-8) and have been reconstituted in artificial membranes
(9-11); cDNA encoding chloride channels have been cloned
and expressed (12, 13). In addition, cloning of the cDNA
encoding cystic fibrosis transmembrane regulatory protein
(14-16) has led to the discovery that this protein is probably
also a chloride channel (17-19). Despite this body of work,
many questions remain about the functional properties of
epithelial chloride channels. We have previously reported the
partial purification and reconstitution of a chloride-channel
protein from Necturus maculosus gallbladder (20), which,
although highly selective for chloride and partially blocked by
the antibody in a lipid bilayer, demonstrated multiple, almost
chaotic, current levels. We now show that no matter the stage
of purification, this channel can adopt different conduc-
tances, the smallest ofwhich is 9 pS, and that channels of this
size are regulated differently from the more conductive ones
in that only the latter are blocked by antibody.
METHODS
Protein Purification. Cells from =25 N. maculosus gall-
bladders were scraped from untreated tissues into 7 ml of
phosphate-buffered saline (PBS) containing 10 mM Na3PO4,
150 mM NaCl, 10 mM EGTA, 1 mM phenylmethylsulfonyl
fluoride, 10 ,ug of aprotinin per ml, 0.1 mM leupeptin, and 1
mM pepstatin. Cells were disrupted by nitrogen cavitation,
and membrane proteins were solubilized in 10 mM 3-[3-
cholamidopropyl)dimethylammonio]-2-hydroxy-1-propane-
sulfonate (CHAPS). Cellular debris was pelleted at 10,000
rpm for 20 min at 4°C. The supernatant was filtered through
a 0.2-,um syringe filter, and 25-30 mg of protein was loaded
onto a 20-ml Sephacryl S-200 column in 0.1% triethanol-
amine/1% CHAPS for desalting and partial size selection.
Approximately 20 mg was contained in the 8-ml high molec-
ular weight fraction [which contains the epitope, as con-
firmed by immunoblot (Western) analysis]. This fraction was
separated by fast protein liquid chromatography (FPLC) with
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a Mono Q column (Pharmacia) in 0.3% triethylamine/1%
CHAPS with a linear NaCl gradient of 0-1.2 M. The high
molecular weight immunoreactive band was eluted at =0.6 M
NaCl. However, this peak still contained a number ofprotein
bands. The final step of purification was immunoaffinity
column chromatography. The column was prepared by pu-
rifying IgG with a Bio-Rad Affi-Gel protein A Maps II kit; the
purified IgG was then coupled to Affi-Gel Hz hydroxide gel
with Bio-Rad's Affi-Gel Hz immunoaffinity kit. The FPLC
Mono Q peak fraction (4 ml) was diluted to 10 ml, Na3PO4 was
added to 50 mM, and protein was bound to the immunoaf-
finity column overnight at 4°C. The column was washed with
40 ml ofPBS containing 0.5 M NaCl and 1% CHAPS, and the
immunoreactive protein was eluted with 15 ml of 3 M
KSCN/0.5 M imidazole/0.5 M NaCl/0.1% Triton X-100.
Silver staining was done with a Bio-Rad Silver Stain kit, and
Western blotting was done as described (20).
Reconstitution and Recording. Planar lipid bilayers were
formed from a mixture of palmitoyl/oleoyl phosphatidyleth-
anolamine and palmitoyl/oleoyl phosphatidylserine as de-
scribed (21). We added solubilized protein (5-15 ,l) directly
to the cis solution as previously described; after incorpo-
ration and recording, the concentration of sodium chloride in
that chamber was changed to a final value of 150 or 200 mM.
Antibody (as obtained from mouse ascites fluid and stored
frozen) was added to the trans side (it has no effect from the
cis side) at a 1:100 dilution.
Bilayers were clamped at voltages from -100 to +100 mV,
with the voltage defined as cis-trans (ground). At positive
holding potentials, currents flowing from cis to trans repre-
sent "outward" currents and are shown as upward transi-
tions in the recordings. Currents were recorded at a band-
width of 2000-3000 Hz and stored on a video cassette
recorder; subsequently they were filtered at 200 Hz, digitized
at 800 Hz, and analyzed.
RESULTS AND DISCUSSION
We prepared a monoclonal antibody that recognizes the cell
membranes from the gallbladder of N. maculosus (21) and
used the antibody to prepare an immunoaffinity column.
Using solubilized protein from the gallbladder cells, we have
been able to purify the protein to apparent homogeneity (Fig.
1).
In an earlier study we reconstituted partially purified
protein into planar lipid bilayers and showed that this mate-
rial forms a highly chloride-selective channel that is at least
partly blocked by the monoclonal antibody used to isolate the
protein (20). Although ion selectivity could be measured,
kinetics of the channel were impossible to obtain because of
the very complicated behavior it displayed. Furthermore,
owing to the appearance of such large and complicated
channels, we were unable to observe smaller channels, since
*To whom reprint requests should be addressed.
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FIG. 1. Silver-stained gel (Left) and Western blot (Right) that
show the same bands. The major band (upper arrow) is the protein
(-219 kDa) previously described. The light band (lower arrow) at
about 85 kDa appeared only during late stages of purification, and is
probably a degradation product; as shown, it is also immunoreactive.
recording at high gain was impossible. One possible cause of
this complex behavior was that different molecular species
were being incorporated. However, our experiments indicate
that the results were identical regardless of the stage of
purification. It is not likely that the smaller band seen in Fig.
1 is the channel-forming moiety, since we never see a band
of this size on Western blots during earlier stages of purifi-
cation when, as noted above, the reconstituted channel is
indistinguishable from that seen with the purified prepara-
tion. That is, no differences can be detected whether we use
(i) material eluted after one-step purification from the immu-
noaffinity column (Figs. 2B and 3), (ii) that obtained from the
center of the only peak seen on FPLC purification of the
immunoaffinity eluate (20), or (iii) the apparently homoge-
neous material (Fig. 1) used for most of the experiments
presented in this paper (Figs. 2 A and C and 3-6).
We found that we could resolve smaller channels by
perfusing the chamber at an early time after insertion: we
repeatedly observed insertion of a far smaller channel gen-
erally before the larger ones appeared (Fig. 2A). Once it
became clear that small channels were in fact present,
experiments could be done without perfusion, and recordings
were made at high gain from the start. In some experiments
we saw multiple small channels without the appearance ofthe
larger ones (Fig. 2B), and in others (Fig. 2C) we saw both
small and large channels (or substates) open at the same time.
The mean conductance of the small channel is 9 pS, and the
reversal potential indicates that it is highly selective for
chloride (Fig. 3) as had been the case for the channel
previously reported. Unlike the case for the high-con-
ductance-state channels (see below and ref. 20), the antibody
has no effect on the single channels; furthermore, there is no
effect of 4,4'-dinitrostilbene-2,2'-disulfonic acid or 5-nitro-2-
(3-phenylpropylamino)benzoic acid at concentrations up to
200 u,M-chemicals which have been shown to block some
other chloride channels at these concentrations, on either the
high- or the low-conductance channels.
The basic unit appears to have a conductance of 9 pS, yet
the apparently pure protein also routinely shows multiple
states. Several possibilities exist: (i) two different protein
species insert into the bilayer, (ii) several identical molecules
(or subunits of that molecule) insert, or (iii) a single molecule
displays multiple substates. The first possibility seems un-
likely because both the small and large channels show 20-fold
selectivity for chloride over sodium and because once we
started seeking the small channel, we have almost never seen
large-channel insertions without one or more 9-pS units also
evident. As to the second possibility, ifwe are to assume that
all of these states represent aggregates of the 9-pS unit, then
there must be, in the bilayers, up to 30 such units. Since the
conductance in any bilayer does not usually increase pro-
gressively with time (that is, the maximum conductance
occurs within at most a few minutes after the first channel is
seen and then remains stable) and since the bilayer is vast in
size compared with a single molecule, these observations in
addition to the apparent cooperative gating imply that any
such aggregation would occur before the protein enters the
bilayer. Finally, there is both precedent (22) and theory (23)
consistent with the appearance of multiple substates of a
single molecule, presumably because of small changes in
conformational states of the channel. The results of studies
with monoclonal antibody E12, the antibody used to purify
the protein, are most consistent with the last possibility.
This antibody blocks the chloride conductance in a number
of tissues from mudpuppy to man (20, 21) and also markedly
reduces the number of open states present in the bilayer
(Figs. 4 and 5). However, the antibody has no effect on the
9-pS channels; indeed, addition of antibody (and it is active
only from the trans side) in the presence of large channels
leads to enough of a decrease in conductance levels that it is
again possible to see 9-pS channels (Fig. 6), although multi-
ple-level gating is not fully abolished.
Multiple substates have been observed many times, both
from patch-clamp recording of either cation (24, 25) or anion
(26) channels and from reconstitution experiments using
either impure (27-29; reviewed in ref. 30) or apparently pure
(22) membrane proteins incorporated into lipid bilayers.
Although in some instances the multiple substates show
similar ion selectivities, different regulatory mechanisms
accounting for the gating of such substates have not been
demonstrated.
The mechanism of such gating is not clear, although it has
been shown (23) on theoretical bases that a number of
subconductance states can exist in a single channel that
assumes small changes in conformation or electrostatic prop-
erties. Were the channel to aggregate in the bilayer, antibody
might bind in some way and prevent the aggregation or the
opening of a "main" gate. Such a gate would have its own
kinetics and upon opening would yield total conductances
that depend on the number of individual units open at the
time. Such a mechanism could explain the frequency of
channel transitions that span several units at one time, as
shown for the chloride channel discussed here. However, as
noted above, aggregation within the bilayer is unlikely. A
more likely mechanism is that antibody binds to a region of
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FIG. 2. (A) Trace of a single channel in a bilayer. (B) Recordings at several voltages of an experiment in which at least three small channels
are present. (C) Trace showing a single 10-pS channel superimposed on one of about 150 pS. The larger transitions appeared several minutes
after the smaller ones. Addition of antibody had no effect on these channels. c, Closed state.
the channel molecule to prevent or limit the changes in
conformation required to form the large conductance states.
It is worthwhile to consider the possible relevance of the
antibody effects to the physiological state of the native
channels. Although monoclonal antibody blocks the chloride





FIG. 3. I-V curve constructed from 10 experiments like those
shown in Fig. 2B. The slope conductance is 9.1 + 0.3 pS, and the
reversal potential with a 200-50 mM NaCl gradient is 30.8 mV,
indicating a PCI/PNa ratio of 19.4, where P is permeability.
(theophylline in the case of N. maculosus gallbladder) in
submaximal doses; however, blockade can always be over-
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FIG. 4. Continuous tracings ofmultiple large channels before and
after antibody addition. The lines represent the zero current level and
are included to clarify the point that we never see complete closing
of all channels when multiple channel gating is present. Antibody is
added at the end of the second trace, and the mixture is stirred for
30 s (record not shown). There clearly is an effect, which begins soon
after the start of the third trace; by the end of the last trace, most of
the large transitions have disappeared.
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FIG. 5. Amplitude histogram of all data at this potential (60 mV),
both before (A) and after (B) the addition of antibody, indicating a
marked shift to smaller transitions and some complete closures.
periments suggest a possible explanation for that finding. If
the channel can exist in both low- and high-conductance
conformations (so they appear to gate either individually or
as aggregates) and if antibody blocks the high-conductance
conformation, one reasonable explanation for the findings in
the cells is that increasing amounts of agonist cause insertion
or activation (or both) of more and more channels. If enough
low-conductance channels form and remain as such, it could
lead to an increase in membrane conductance that is anti-
body-independent, since antibody affects only the ability to
form the high-conductance states. Such a phenomenon could
also lead to different control mechanisms for total-cell chlo-
ride conductance, since the high- and low-conductance chan-
nels could be controlled separately. Of interest in this regard
is that we have shown recently (31) that the high-conductance
channel is regulated in the bilayer by phosphorylation and
dephosphorylation. However, there is no effect of cyclic
AMP-dependent protein kinase on the 9-pS channel, again
indicating independent regulation of the gating mechanisms
for the single channel and for the aggregates. This type of
mechanism may also explain the multiple conductance states





FIG. 6. Traces 5 min after antibody addition at a potential of -50
mV. This record is highly filtered because of the low gain used in the
experiment. The lines are drawn to be equidistant between the zero
current value and the largest current seen in the bilayer, indicating
the presence of six channels, each with a conductance of 8.6 pS.
Although there are still several transitions that include multiple units,
there are no current levels any higher than these.
separate control mechanisms exist for single channels and for
aggregates or other cooperative conductance states of those
channels.
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